54 related articles for article (PubMed ID: 38652967)
1. Kynurenine promotes neonatal heart regeneration by stimulating cardiomyocyte proliferation and cardiac angiogenesis.
Zhang D; Ning J; Ramprasath T; Yu C; Zheng X; Song P; Xie Z; Zou MH
Nat Commun; 2022 Oct; 13(1):6371. PubMed ID: 36289221
[TBL] [Abstract][Full Text] [Related]
2. Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases.
Murakami Y; Hoshi M; Imamura Y; Arioka Y; Yamamoto Y; Saito K
Mediators Inflamm; 2013; 2013():391984. PubMed ID: 23476103
[TBL] [Abstract][Full Text] [Related]
3. Impaired tryptophan metabolism by type 2 inflammation in epithelium worsening asthma.
Miao Y; Zhong C; Bao S; Wei K; Wang W; Li N; Bai C; Chen W; Tang H
iScience; 2024 Jun; 27(6):109923. PubMed ID: 38799558
[TBL] [Abstract][Full Text] [Related]
4. The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease.
Zinger A; Barcia C; Herrero MT; Guillemin GJ
Parkinsons Dis; 2011; 2011():716859. PubMed ID: 21687761
[TBL] [Abstract][Full Text] [Related]
5. A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1).
Gonçalves M; Furgiuele A; Rasini E; Legnaro M; Ferrari M; Luini A; Rodrigues-Santos P; Caramelo F; Marino F; Pereira FC; Cosentino M
Eur J Pharmacol; 2024 Apr; 968():176420. PubMed ID: 38367683
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
Front Immunol; 2022; 13():832263. PubMed ID: 35371054
[TBL] [Abstract][Full Text] [Related]
7. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase (IDO1) - Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson's Disease?
Gonçalves M; Rodrigues-Santos P; Januário C; Cosentino M; Pereira FC
Int Immunopharmacol; 2024 May; 133():112062. PubMed ID: 38652967
[TBL] [Abstract][Full Text] [Related]
9. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process.
Salminen A
Ageing Res Rev; 2022 Mar; 75():101573. PubMed ID: 35085834
[TBL] [Abstract][Full Text] [Related]
10. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
Labadie BW; Bao R; Luke JJ
Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
